Wollenhaupt, Jürgen
Lee, Eun-Bong
Curtis, Jeffrey R.
Silverfield, Joel
Terry, Ketti
Soma, Koshika
Mojcik, Chris
DeMasi, Ryan
Strengholt, Sander
Kwok, Kenneth
Lazariciu, Irina
Wang, Lisy
Cohen, Stanley
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 8 June 2018
Accepted: 18 March 2019
First Online: 5 April 2019
Ethics approval and consent to participate
: This study was conducted in accordance with the International Ethical Guidelines for Biomedical Research Involving Human Subjects, the Declaration of Helsinki, and the Good Clinical Practice Guidelines, along with applicable local regulatory requirements and laws. The study protocol was approved by the Institutional Review Boards and/or Independent Ethics Committee at each study center. All patients provided written, informed consent.
: Not applicable.
: JW and SC are consultants for, and have received speaker fees and honoraria from, Pfizer Inc. EBL is a consultant for Pfizer Inc and has received grant/research support from Green Cross Corporation and Hammi Pharm. JRC has received grant/research support and consultant fees from Pfizer Inc. JS has received grant/research support and speaker fees from Pfizer Inc. KT, KS, CM, RD, SS, KW, and LW are employees of, and hold shares in, Pfizer Inc. IL is an employee of IQVIA and a consultant for Pfizer Inc.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.